Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network

Cell

Volumn 133, Issue 6, 2008, Pages 1019-1031

  Kuilman, Thomas ^a   Michaloglou, Chrysiis ^a   Vredeveld, Liesbeth C W ^a   Douma, Sirith ^a   van Doorn, Remco ^a   Desmet, Christophe J ^a   Aarden, Lucien A ^b   Mooi, Wolter J ^c   Peeper, Daniel S ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

HUMDISEASE; PROTEINS; SIGNALING

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; TRANSCRIPTION FACTOR; TRANSCRIPTOME;

ARTICLE; COLON ADENOMA; EPITHELIUM; GENE INDUCTION; HUMAN; HUMAN CELL; INFLAMMATION; MITOGENESIS; NEOPLASM; ONCOGENE; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; SENESCENCE;

EID: 44649101304     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2008.03.039     Document Type: Article

References (52)

1. Acosta J.C., O'Loghlen A., Banito A., Guijarro M.V., Augert A., Raguz S., Fumagalli M., Da Costa M., Brown C., Popov N., et al. Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence. Cell 133 (2008) 1006-1018 this issue
2. Adams P.D. Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene 397 (2007) 84-93
3. Ancrile B., Lim K.H., and Counter C.M. Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. Genes Dev. 21 (2007) 1714-1719
4. Bartkova J., Rezaei N., Liontos M., Karakaidos P., Kletsas D., Issaeva N., Vassiliou L.V., Kolettas E., Niforou K., Zoumpourlis V.C., et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444 (2006) 633-637
5. Beausejour C.M., Krtolica A., Galimi F., Narita M., Lowe S.W., Yaswen P., and Campisi J. Reversal of human cellular senescence: Roles of the p53 and p16 pathways. EMBO J. 22 (2003) 4212-4222
6. Berns K., Hijmans E.M., Mullenders J., Brummelkamp T.R., Velds A., Heimerikx M., Kerkhoven R.M., Madiredjo M., Nijkamp W., Weigelt B., et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428 (2004) 431-437
7. Braig M., Lee S., Loddenkemper C., Rudolph C., Peters A.H., Schlegelberger B., Stein H., Dorken B., Jenuwein T., and Schmitt C.A. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436 (2005) 660-665
8. Brakenhoff J.P., de Hon F.D., Fontaine V., ten Boekel E., Schooltink H., Rose-John S., Heinrich P.C., Content J., and Aarden L.A. Development of a human interleukin-6 receptor antagonist. J. Biol. Chem. 269 (1994) 86-93
9. Campisi J. Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors. Cell 120 (2005) 513-522
10. Chen Z., Trotman L.C., Shaffer D., Lin H.K., Dotan Z.A., Niki M., Koutcher J.A., Scher H.I., Ludwig T., Gerald W., et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436 (2005) 725-730
11. Collado M., Gil J., Efeyan A., Guerra C., Schuhmacher A.J., Barradas M., Benguria A., Zaballos A., Flores J.M., Barbacid M., et al. Tumour biology: Senescence in premalignant tumours. Nature 436 (2005) 642
12. Courtois-Cox S., Genther Williams S.M., Reczek E.E., Johnson B.W., McGillicuddy L.T., Johannessen C.M., Hollstein P.E., MacCollin M., and Cichowski K. A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell 10 (2006) 459-472
13. Dai C.Y., Furth E.E., Mick R., Koh J., Takayama T., Niitsu Y., and Enders G.H. p16(INK4a) expression begins early in human colon neoplasia and correlates inversely with markers of cell proliferation. Gastroenterology 119 (2000) 929-942
14. Dankort D., Filenova E., Collado M., Serrano M., Jones K., and McMahon M. A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. Genes Dev. 21 (2007) 379-384
15. Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S., Teague J., Woffendin H., Garnett M.J., Bottomley W., et al. Mutations of the BRAF gene in human cancer. Nature 417 (2002) 949-954
16. Denoyelle C., Abou-Rjaily G., Bezrookove V., Verhaegen M., Johnson T.M., Fullen D.R., Pointer J.N., Gruber S.B., Su L.D., Nikiforov M.A., et al. Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat. Cell Biol. 8 (2006) 1053-1063
17. Di Micco R., Fumagalli M., Cicalese A., Piccinin S., Gasparini P., Luise C., Schurra C., Garre M., Nuciforo P.G., Bensimon A., et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444 (2006) 638-642
18. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92 (1995) 9363-9367
19. Dirac A.M., and Bernards R. Reversal of senescence in mouse fibroblasts through lentiviral suppression of p53. J. Biol. Chem. 278 (2003) 11731-11734
20. Finkel T., Serrano M., and Blasco M.A. The common biology of cancer and ageing. Nature 448 (2007) 767-774
21. Garnett M.J., and Marais R. Guilty as charged: B-RAF is a human oncogene. Cancer Cell 6 (2004) 313-319
22. Gomis R.R., Alarcon C., Nadal C., Van Poznak C., and Massague J. C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell 10 (2006) 203-214
23. Gray-Schopfer V.C., Cheong S.C., Chong H., Chow J., Moss T., Abdel-Malek Z.A., Marais R., Wynford-Thomas D., and Bennett D.C. Cellular senescence in naevi and immortalisation in melanoma: A role for p16?. Br. J. Cancer 95 (2006) 496-505
24. Ha L., Ichikawa T., Anver M., Dickins R., Lowe S., Sharpless N.E., Krimpenfort P., Depinho R.A., Bennett D.C., Sviderskaya E.V., et al. ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence. Proc. Natl. Acad. Sci. USA 104 (2007) 10968-10973
25. Hirano T., and Kishimoto T. Interleukin-6: Possible implications in human diseases. Ric. Clin. Lab. 19 (1989) 1-10
26. Hodge D.R., Xiao W., Clausen P.A., Heidecker G., Szyf M., and Farrar W.L. Interleukin-6 regulation of the human DNA methyltransferase (HDNMT) gene in human erythroleukemia cells. J. Biol. Chem. 276 (2001) 39508-39511
27. Hong D.S., Angelo L.S., and Kurzrock R. Interleukin-6 and its receptor in cancer: Implications for Translational Therapeutics. Cancer 110 (2007) 1911-1928
28. Kalai M., Montero-Julian F.A., Brakenhoff J.P., Fontaine V., De Wit L., Wollmer A., Brailly H., Content J., and Grotzinger J. Analysis of the mechanism of action of anti-human interleukin-6 and anti-human interleukin-6 receptor-neutralising monoclonal antibodies. Eur. J. Biochem. 249 (1997) 690-700
29. Kortlever R.M., Higgins P.J., and Bernards R. Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat. Cell Biol. 8 (2006) 877-884
30. Krimpenfort P., Ijpenberg A., Song J.Y., van der Valk M., Nawijn M., Zevenhoven J., and Berns A. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a. Nature 448 (2007) 943-946
31. Krtolica A., Parrinello S., Lockett S., Desprez P.Y., and Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging. Proc. Natl. Acad. Sci. USA 98 (2001) 12072-12077
32. Lloyd A.C., Obermuller F., Staddon S., Barth C.F., McMahon M., and Land H. Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev. 11 (1997) 663-677
33. Lowe S.W., Cepero E., and Evan G. Intrinsic tumour suppression. Nature 432 (2004) 307-315
34. Lu C., and Kerbel R.S. Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J. Cell Biol. 120 (1993) 1281-1288
35. Mallette F.A., Gaumont-Leclerc M.F., and Ferbeyre G. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev. 21 (2007) 43-48
36. Mason D.X., Jackson T.J., and Lin A.W. Molecular signature of oncogenic ras-induced senescence. Oncogene 23 (2004) 9238-9246
37. Michaloglou C., Vredeveld L.C., Soengas M.S., Denoyelle C., Kuilman T., van der Horst C.M., Majoor D.M., Shay J.W., Mooi W.J., and Peeper D.S. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436 (2005) 720-724
38. Mooi W.J., and Peeper D.S. Oncogene-induced cell senescence-halting on the road to cancer. N. Engl. J. Med. 355 (2006) 1037-1046
39. Narita M., Nunez S., Heard E., Narita M., Lin A.W., Hearn S.A., Spector D.L., Hannon G.J., and Lowe S.W. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113 (2003) 703-716
40. Nicke B., Bastien J., Khanna S.J., Warne P.H., Cowling V., Cook S.J., Peters G., Delpuech O., Schulze A., Berns K., et al. Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth arrest in human ovarian surface epithelial cells. Mol. Cell 20 (2005) 673-685
41. Peeper D.S., Shvarts A., Brummelkamp T., Douma S., Koh E.Y., Daley G.Q., and Bernards R. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence. Nat. Cell Biol. 4 (2002) 148-153
42. Ramji D.P., and Foka P. CCAAT/enhancer-binding proteins: Structure, function and regulation. Biochem. J. 365 (2002) 561-575
43. Rowland B.D., Bernards R., and Peeper D.S. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat. Cell Biol. 7 (2005) 1074-1082
44. Sage J., Miller A.L., Perez-Mancera P.A., Wysocki J.M., and Jacks T. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424 (2003) 223-228
45. Schnabl B., Purbeck C.A., Choi Y.H., Hagedorn C.H., and Brenner D. Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype. Hepatology 37 (2003) 653-664
46. Sebastian T., Malik R., Thomas S., Sage J., and Johnson P.F. C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence. EMBO J. 24 (2005) 3301-3312
47. Shay J.W., and Wright W.E. Senescence and immortalization: Role of telomeres and telomerase. Carcinogenesis 26 (2005) 867-874
48. Sherr C.J. Principles of tumor suppression. Cell 116 (2004) 235-246
49. Sparmann A., and Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6 (2004) 447-458
50. Tremain R., Marko M., Kinnimulki V., Ueno H., Bottinger E., and Glick A. Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras. Oncogene 19 (2000) 1698-1709
51. Xue W., Zender L., Miething C., Dickins R.A., Hernando E., Krizhanovsky V., Cordon-Cardo C., and Lowe S.W. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445 (2007) 656-660
52. Ye X., Zerlanko B., Kennedy A., Banumathy G., Zhang R., and Adams P.D. Downregulation of Wnt signaling is a trigger for formation of facultative heterochromatin and onset of cell senescence in primary human cells. Mol. Cell 27 (2007) 183-196